(Q43259457)

English

Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins

scientific article published on 16 October 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Richard Scolyer

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Rajmohan Murali

3

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

author name string

Liqing Zhuang

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Stanley W McCarthy

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

John F Thompson

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Peter Hersey

7

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

publication date

16 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Modern Pathology

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

45-53

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

https://scigraph.springernature.com/pub.10.1038/modpathol.2009.129

0 references

Prognostic significance of melanoma inhibiting activity levels in malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.129

21 January 2018

Lactate dehydrogenase isoenzymes 1 and 5: differential expression by neoplastic and stromal cells in non-small cell lung cancer and other epithelial malignant tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.129

21 January 2018

On the Origin of Cancer Cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.129

21 January 2018

Harnessing the hypoxia-inducible factor in cancer and ischemic disease

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.129

21 January 2018

Adaptation to ER stress as a driver of malignancy and resistance to therapy in human melanoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.129

21 January 2018

A23187, ionomycin and thapsigargin upregulate mRNA of HIF-1alpha via endoplasmic reticulum stress rather than a rise in intracellular calcium

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.129

21 January 2018

Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.129

21 January 2018

Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.129

21 January 2018

Lactate: mirror and motor of tumor malignancy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.129

21 January 2018

A phase I study of the pan bcl-2 family inhibitor obatoclax mesylate in patients with advanced hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.129

21 January 2018

Glucose-regulated protein 78 antagonizes cisplatin and adriamycin in human melanoma cells.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.129

21 January 2018

Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.129

21 January 2018

Role of the unfolded protein response in cell death

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.129

21 January 2018

Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.129

21 January 2018

Lactate Dehydrogenase 5 Expression in Operable Colorectal Cancer: Strong Association With Survival and Activated Vascular Endothelial Growth Factor Pathway—A Report of the Tumour Angiogenesis Research Group

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.129

21 January 2018

Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.129

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for survival of patients treated systemically for disseminated melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.129

7 January 2021

based on heuristic

inferred from DOI database lookup

S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.129

7 January 2021

based on heuristic

inferred from DOI database lookup

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.129

7 January 2021

based on heuristic

inferred from DOI database lookup

Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.129

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MODPATHOL.2009.129

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43259457&oldid=1985047238"